$3.84
-0.15[-3.76%]
Last update: 8:20AM Get Real Time Here
Intensity Therapeutics
(NASDAQ:INTS)Intensity Therapeutics Stock (NASDAQ:INTS), Analyst Ratings, Price Targets, Predictions
Intensity Therapeutics Inc has a consensus price target of $12, established from looking at the 4 latest analyst ratings. The last 3 analyst ratings were released from Benchmark, Benchmark, and Benchmark on March 21, 2024, November 14, 2023, and August 24, 2023. With an average price target of $12 between Benchmark, Benchmark, and Benchmark, there's an implied 212.50% upside for Intensity Therapeutics Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Benchmark
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Intensity Therapeutics
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/21/2024 | INTS | Buy Now | Intensity Therapeutics | $3.84 | 212.5% | Benchmark | Robert Wasserman | → $12 | Reiterates | Speculative Buy → Speculative Buy | Get Alert |
| 11/14/2023 | INTS | Buy Now | Intensity Therapeutics | $3.84 | 212.5% | Benchmark | Robert Wasserman | → $12 | Reiterates | Speculative Buy → Speculative Buy | Get Alert |
| 08/24/2023 | INTS | Buy Now | Intensity Therapeutics | $3.84 | 212.5% | Benchmark | Robert Wasserman | → $12 | Reiterates | Speculative Buy → Speculative Buy | Get Alert |
| 07/18/2023 | INTS | Buy Now | Intensity Therapeutics | $3.84 | 212.5% | Benchmark | Robert Wasserman | → $12 | Initiates | → Speculative Buy | Get Alert |
FAQ
What is the target price for Intensity Therapeutics (INTS)?
The latest price target for Intensity Therapeutics (NASDAQ: INTS) was reported by Benchmark on March 21, 2024. The analyst firm set a price target for $12.00 expecting INTS to rise to within 12 months (a possible 212.50% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Intensity Therapeutics (INTS)?
The latest analyst rating for Intensity Therapeutics (NASDAQ: INTS) was provided by Benchmark, and Intensity Therapeutics reiterated their speculative buy rating.
When was the last upgrade for Intensity Therapeutics (INTS)?
There is no last upgrade for Intensity Therapeutics.
When was the last downgrade for Intensity Therapeutics (INTS)?
There is no last downgrade for Intensity Therapeutics.
When is the next analyst rating going to be posted or updated for Intensity Therapeutics (INTS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Intensity Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Intensity Therapeutics was filed on March 21, 2024 so you should expect the next rating to be made available sometime around March 21, 2025.
Is the Analyst Rating Intensity Therapeutics (INTS) correct?
While ratings are subjective and will change, the latest Intensity Therapeutics (INTS) rating was a reiterated with a price target of $0.00 to $12.00. The current price Intensity Therapeutics (INTS) is trading at is $3.84, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.